{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:11:08Z","timestamp":1769202668513,"version":"3.49.0"},"reference-count":15,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018,5,25]]},"DOI":"10.1253\/circj.cj-17-1425","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T22:25:21Z","timestamp":1521584721000},"page":"1487-1490","source":"Crossref","is-referenced-by-count":9,"title":["First Approval of Improved Medical Device Conditional on Use-Result Survey in Japan\u3000\u2015 Regulatory Review of Polymer-Free Drug-Coated BioFreedom Coronary Stent \u2015"],"prefix":"10.1253","volume":"82","author":[{"given":"Akihide","family":"Konishi","sequence":"first","affiliation":[{"name":"Office of Medical Device III, Pharmaceuticals and Medical Devices Agency"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Ho","sequence":"additional","affiliation":[{"name":"Office of Medical Device III, Pharmaceuticals and Medical Devices Agency"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Shirai","sequence":"additional","affiliation":[{"name":"Office of Medical Device III, Pharmaceuticals and Medical Devices Agency"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Shirato","sequence":"additional","affiliation":[{"name":"Office of Medical Device III, Pharmaceuticals and Medical Devices Agency"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. Ide K. Medical device regulations and utilization of international standards in Japan. Tokyo: Pharmaceuticals and Medical Devices Agency http:\/\/www.mhlw.go.jp\/file\/04-Houdouhappyou-11123000-Iyakushokuhinkyoku-Shinsakanrika\/regulation_medicaldevices.pdf (accessed January 12, 2018)."},{"key":"2","unstructured":"2. Pharmaceuticals and Medical Devices Agency. Differences among brand-new medical devices, improved medical devices and generic medical devices (in Japanese). Available at: https:\/\/www.pmda.go.jp\/files\/000155726.pdf (accessed January 12, 2018)."},{"key":"3","unstructured":"3. Pharmaceuticals and Medical Devices Agency. Re-examination system under the old pharmaceutical affairs law (in Japanese). Available at: https:\/\/www.pmda.go.jp\/review-services\/reexamine-reevaluate\/re-examinations\/0005.html (accessed January 12, 2018)."},{"key":"4","unstructured":"4. Pharmaceuticals and Medical Devices Agency. Use-results survey system under the pharmaceuticals and medical devices act (in Japanese). Available at: https:\/\/www.pmda.go.jp\/files\/000160083.pdf (accessed January 12, 2018)."},{"key":"5","unstructured":"5. Pharmaceuticals and Medical Devices Agency. Fundamental point of view about use-results survey system (in Japanese). Available at: https:\/\/www.pmda.go.jp\/files\/000197726.pdf (accessed January 12, 2018)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Urban P, Meredith IT, Abizaid A, Pocock SJ, Carri\u00e9 D, Naber C, et al. Polymer-free drug-coated coronary stents in patients at high bleeding risk. <i>N Engl J Med<\/i> 2015; 373: 2038\u20132047.","DOI":"10.1056\/NEJMoa1503943"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Garot P, Morice MC, Tresukosol D, Pocock SJ, Meredith IT, Abizaid A, et al. 2-Year outcomes of high bleeding risk patients after polymer-free drug-coated stents. <i>J Am Coll Cardiol<\/i> 2017; 69: 162\u2013171.","DOI":"10.1016\/j.jacc.2016.10.009"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ikari Y, Kotani J, Kozuma K, Kyo E, Nakamura M, Yokoi H. Assessment of sirolimus-eluting coronary stent implantation with aspirin plus low-dose ticlopidine administration: One year results from CYPHER Stent Japan Post-Marketing Surveillance Registry (J-PMS). <i>Circ J<\/i> 2009; 73: 1038\u20131044.","DOI":"10.1253\/circj.CJ-08-0732"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Aoki J, Kozuma K, Awata M, Nanasato M, Shiode N, Tanabe K, et al. Three-year clinical outcome of everolimus-eluting stents from the post-marketing surveillance study of cobalt-chromium everolimus-eluting stent (Xience V\/PROMUS) in Japan. <i>Circ J<\/i> 2006; 80: 906\u2013912.","DOI":"10.1253\/circj.CJ-15-1181"},{"key":"10","unstructured":"10. BioFreedom Stent (Package insert; in Japanese). https:\/\/www.cordisjapan.jp\/content\/dam\/cordis\/web\/documents\/ifu\/cordis-jp-biofreedom-ifu.pdf (accessed March 9, 2018)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Costa RA, Abizaid A, Mehran R, Schofer J, Schuler GC, Hauptmann KE, et al. Polymer-free biolimus A9-coated stents in the treatment of de novo coronary lesions 4- and 12-month angiographic follow-up and final 5-year clinical outcomes of the prospective, multicenter BioFreedom FIM Clinical Trial. <i>JACC Cardiovasc Interv<\/i> 2016; 9: 52\u201364.","DOI":"10.1016\/j.jcin.2015.09.008"},{"key":"12","unstructured":"12. Lee SWL, Chan KKW, Lam SCC. The first establishment of early healing profile &amp; 9-month outcomes of a new \u201cpolymer-free\u201d Biolimus-A9 drug-coated-stent by longitudinal sequential OCT assessments: The EGO-BioFreedom Study. Euro PCR 2015, Paris."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Konishi A, Isobe S, Sato D. New regulatory framework for medical devices in Japan: Current regulatory considerations regarding clinical studies. <i>J Vasc Interv Radiol<\/i> 2018; 29: 657\u2013660.","DOI":"10.1016\/j.jvir.2017.12.022"},{"key":"14","unstructured":"14. Pharmaceuticals and Medical Devices Agency. Cook spectrum M\/R impregnated central venous catheter review report 2015 (in Japanese). Available at: http:\/\/www.pmda.go.jp\/medical_devices\/2015\/M20151009001\/250288000_22700BZX00263000_A100_1.pdf (accessed January 12, 2018)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, et al. A comparison of two antimicrobial-impregnated central venous catheters. <i>N Engl J Med<\/i> 1999; 340: 1\u20138.","DOI":"10.1056\/NEJM199901073400101"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/6\/82_CJ-17-1425\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T05:41:19Z","timestamp":1570945279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/6\/82_CJ-17-1425\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,25]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-1425","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,25]]}}}